Structual and Calcium Regulatory Proteins in Sarcopenia
Structual and Calcium Regulatory Proteins in Sarcopenia
批准号:
8078074
负责人:
LaDora V Thompson
金额:
$26.34万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-06-01 至 2013-05-31
关键词:
ActinsAdenovirusesAgeAgingAmino AcidsAnimalsBiochemistryBiological AssayCalciumChemicalsElderlyFiberFunctional disorderGene TransferGoalsHealthInvestigationLinkLongevityModelingModificationMolecularMolecular BiologyMuscleMuscle ProteinsMyosin ATPaseMyosin Alkali Light ChainsMyosin Light ChainsPeptidesPerformancePhysiologicalPhysiologyPost-Translational Protein ProcessingPreparationProgress ReportsProtein IsoformsProteinsProteomicsPublicationsRattusRecombinantsResearchResearch DesignRoleSiteSkeletal MuscleSpeedStructureTechniquesTechnologyTestingTissuesTroponin CYouthage effectage groupage relatedagedarmgenetic regulatory proteinin vivoloss of functionmuscle agingnovelprematurepreventprotein expressionprotein functionprotein structureprotein structure functionrepairedresearch studysarcopenia
中文摘要
描述(由申请人提供):我们的长期目标是确定骨骼肌性能随年龄下降的分子机制。我们假设关键骨骼肌蛋白中特定氨基酸残基的年龄依赖性损伤通过改变蛋白质结构和功能影响骨骼肌性能。为了支持这一假设,我们之前的研究清楚地表明,比力的下降部分是由于位点特异性翻译后修饰导致肌球蛋白结构的变化。然而,肌球蛋白的变化并不能解释与年龄相关的全部肌肉功能障碍。我们之前的研究结果表明,年龄诱导的钙敏感性改变,强烈暗示了肌钙蛋白c。II型纤维的缩短速度显著降低,这不能用肌凝蛋白异构体转换来解释,这表明调节蛋白,肌凝蛋白轻链,参与其中。这一提议有两个目的:确定肌钙蛋白C在年龄相关性骨骼肌功能障碍(钙敏感性降低)中的作用。我们预测肌钙蛋白C中的特定氨基酸随着年龄的增长而改变,使蛋白质对钙的敏感性降低。目标2。确定肌球蛋白轻链(MLC1f和MLC3f)在年龄相关性骨骼肌功能障碍(收缩速度降低)中的作用。为了从机械上测试这两种蛋白质是如何导致肌肉功能障碍的,我们将使用三种方法。首先,我们将从不同年龄的大鼠中纯化肌钙蛋白C和肌球蛋白轻链,并测试它们的生理相互作用。其次,我们将利用蛋白质组学技术确定翻译后化学修饰的体内类型和修饰的特定氨基酸位点。第三,我们将使用重组腺病毒技术在不同年龄的大鼠中过表达特定的肌球蛋白轻链异构体,以测试蛋白质表达的改变如何直接促进收缩减缓的机制。Fischer 344大鼠将是我们的衰老模型,集中在三个年龄组(成年,老年和老年),代表动物的寿命。这项拟议的研究汇集了一个强大的研究团队和技术组合,包括生理学,生物化学,蛋白质组学和分子生物学,以测试有关肌钙蛋白C和肌球蛋白轻链在衰老中的新作用的基本问题。一旦我们掌握了化学修饰的类型和修饰的具体位置,我们将能够测试这些体内修饰是否会随着年龄的增长而改变蛋白质结构/功能。公共卫生相关性:在衰老过程中,适当转录的肽和蛋白质在结构上发生改变的机会很多。先前的研究表明,由于翻译后修饰,改变蛋白的积累与功能丧失有关。因此,确定衰老过程中特定蛋白质的改变并确定它们在与年龄相关的肌肉功能障碍中的作用至关重要。目前,年龄相关的特定蛋白质氨基酸的翻译后修饰对关键骨骼肌蛋白的蛋白质结构和蛋白质功能的作用尚不清楚。本研究研究了两个关键的骨骼肌蛋白,肌钙蛋白C和肌球蛋白轻链,它们是解释年龄相关肌肉功能障碍的候选蛋白。
英文摘要
DESCRIPTION (provided by applicant): Our long term goal is to determine the molecular mechanisms underlying the diminished skeletal muscle performance with age. We hypothesize that age-dependent damage of specific amino acid residues in key skeletal muscle proteins impacts skeletal muscle performance by altering protein structure and function. In support of this hypothesis, our previous investigations clearly demonstrate that the decline in specific force is due, in part, to changes in the structure of myosin resulting from site-specific post-translational modifications. However, changes in myosin do not explain the total age-related muscle dysfunction. Our previous findings indicate an age-induced alteration in calcium sensitivity, strongly implicating Troponin C. There is a significant reduction in shortening velocity in type II fibers that cannot be explained by myosin isoform switching, suggesting that the regulatory proteins, myosin light chains, are involved. This proposal has two aims: AIM 1. Determine the role of Troponin C in age-related skeletal muscle dysfunction (reduction in calcium sensitivity). We predict that specific amino acids are modified in Troponin C with age, rendering the protein less sensitive to calcium. AIM 2. Determine the role of myosin light chains (MLC1f and MLC3f) in age-related skeletal muscle dysfunction (reduction in contraction velocity). In order to test mechanistically how these two proteins contribute to muscle dysfunction we will use three approaches. First, we will purify Troponin C and myosin light chains from different aged rats and test their physiological interactions. Second we will identify the in vivo type of post-translational chemical modification and the specific amino acid site of modification using proteomic technology. Third, we will use Recombinant Adenovirus technology to over-express specific myosin light chain isoforms in different aged rats to test mechanistically how alterations in protein expression contribute directly to the slowing of contraction. The Fischer 344 rat will be our aging model concentrating on three age groups (adult, old and aged) representing the lifespan of the animal. This proposed research brings together a powerful research team and a combination of techniques, including physiology, biochemistry, proteomics, and molecular biology to test fundamental questions regarding novel roles for Troponin C and myosin light chains in aging. Once we are armed with the type of chemical modification and the specific site of modification, we will be able to test if these in vivo modifications are responsible for altered protein structure/function with age. PUBLIC HEALTH RELEVANCE: During aging there are many opportunities for appropriately transcribed peptides and proteins to become structurally altered. Previous studies show that accumulation of altered proteins, due to post-translational modifications, is correlated with a loss of function. Therefore, it is critical to identify the alterations of specific proteins during aging and to define their roles in age-related muscle dysfunction. Presently, the role of age- related post-translational modifications of specific protein amino acids on protein structure and protein function in key skeletal muscle proteins is unknown. This proposal investigates two key skeletal muscle proteins, Troponin C and myosin light chains, which are candidates to explain age-related muscle dysfunction.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Academic Leadership Award - The Translational Rehabilitation in Geroscience Initiative
-
批准号:10201136
-
项目类别:
-
资助金额:$16.2万
-
财政年份:2021
-
负责人:LaDora V Thompson
-
依托单位:
Academic Leadership Award - The Translational Rehabilitation in Geroscience Initiative
-
批准号:10592362
-
项目类别:
-
资助金额:$15.8万
-
财政年份:2021
-
负责人:LaDora V Thompson
-
依托单位:
Academic Leadership Award - The Translational Rehabilitation in Geroscience Initiative
-
批准号:10380879
-
项目类别:
-
资助金额:$16.0万
-
财政年份:2021
-
负责人:LaDora V Thompson
-
依托单位:
Structual and Calcium Regulatory Proteins in Sarcopenia
-
批准号:7888620
-
项目类别:
-
资助金额:$4.96万
-
财政年份:2009
-
负责人:LaDora V Thompson
-
依托单位:
Training Grant: Functional Proteomics of Aging
-
批准号:8064758
-
项目类别:
-
资助金额:$26.63万
-
财政年份:2008
-
负责人:LaDora V Thompson
-
依托单位:
Training Grant: Functional Proteomics of Aging
-
批准号:7807134
-
项目类别:
-
资助金额:$25.21万
-
财政年份:2008
-
负责人:LaDora V Thompson
-
依托单位:
Training Grant: Functional Proteomics of Aging
-
批准号:7434885
-
项目类别:
-
资助金额:$17.55万
-
财政年份:2008
-
负责人:LaDora V Thompson
-
依托单位:
Training Grant: Functional Proteomics of Aging
-
批准号:8248739
-
项目类别:
-
资助金额:$25.64万
-
财政年份:2008
-
负责人:LaDora V Thompson
-
依托单位:
Training Grant: Functional Proteomics of Aging
-
批准号:7597010
-
项目类别:
-
资助金额:$21.88万
-
财政年份:2008
-
负责人:LaDora V Thompson
-
依托单位:
2007 Aging, Biology of Gordon Conference
-
批准号:7329978
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2007
-
负责人:LaDora V Thompson
-
依托单位:
Myosin Modifications in Aged Muscle
-
批准号:6699971
-
项目类别:
-
资助金额:$10.81万
-
财政年份:2003
-
负责人:LaDora V Thompson
-
依托单位:
Myosin Modifications in Aged Muscle
-
批准号:6569508
-
项目类别:
-
资助金额:$10.83万
-
财政年份:2003
-
负责人:LaDora V Thompson
-
依托单位:
Myosin Modifications in Aged Muscle
-
批准号:6836507
-
项目类别:
-
资助金额:$10.81万
-
财政年份:2003
-
负责人:LaDora V Thompson
-
依托单位:
Myosin Modifications in Aged Muscle
-
批准号:7176158
-
项目类别:
-
资助金额:$10.81万
-
财政年份:2003
-
负责人:LaDora V Thompson
-
依托单位:
Myosin Modifications in Aged Muscle
-
批准号:7010697
-
项目类别:
-
资助金额:$10.81万
-
财政年份:2003
-
负责人:LaDora V Thompson
-
依托单位:
Structural and Calcium Regulatory Proteins in Sarcopenia
-
批准号:6899185
-
项目类别:
-
资助金额:$30.94万
-
财政年份:2001
-
负责人:LaDora V Thompson
-
依托单位:
Structual and Calcium Regulatory Proteins in Sarcopenia
-
批准号:7667956
-
项目类别:
-
资助金额:$26.76万
-
财政年份:2001
-
负责人:LaDora V Thompson
-
依托单位:
Structual and Calcium Regulatory Proteins in Sarcopenia
-
批准号:8278560
-
项目类别:
-
资助金额:$26.33万
-
财政年份:2001
-
负责人:LaDora V Thompson
-
依托单位:
Structual and Calcium Regulatory Proteins in Sarcopenia
-
批准号:7531322
-
项目类别:
-
资助金额:$26.77万
-
财政年份:2001
-
负责人:LaDora V Thompson
-
依托单位:
Structural and Calcium Regulatory Proteins in Sarcopenia
-
批准号:6332163
-
项目类别:
-
资助金额:$32.45万
-
财政年份:2001
-
负责人:LaDora V Thompson
-
依托单位:
海外基金